首页> 美国卫生研究院文献>Biochemical Journal >Caspase-1 (interleukin-1beta-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9.
【2h】

Caspase-1 (interleukin-1beta-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9.

机译:Caspase-1(白介素-1β转化酶)被人丝氨酸蛋白酶抑制剂类似物蛋白酶抑制剂9抑制。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The regulation of caspases, cysteine proteinases that cleave their substrates after aspartic residues, is poorly understood, even though they are involved in tightly regulated cellular processes. The recently discovered serpin analogue proteinase inhibitor 9 (PI9) is unique among human serpin analogues in that it has an acidic residue in the putative specificity-determining position of the reactive-site loop. We measured the ability of PI9 to inhibit the amidolytic activity of several caspases. The hydrolysis of peptide substrates by caspase-1 (interleukin-1beta-converting enzyme), caspase-4 and caspase-8 is inhibited by PI9 in a time-dependent manner. The rate of reaction of caspase-1 with PI9, as well as the rate of substrate hydrolysis of the initial caspase-PI9 complex, shows a hyperbolic dependence on the concentration of PI9, indicative of a two-step kinetic mechanism for inhibition with an apparent second-order rate constant of 7x10(2) M(-1).s(-1). The hydrolysis of a tetrapeptide substrate by caspase-3 is not inhibited by PI9. The complexes of caspase-1 and caspase-4 with PI9 can be immunoprecipitated but no complex with caspase-3 can be detected. No complex can be immunoprecipitated if the active site of the caspase is blocked with a covalent inhibitor. These results show that PI9 is an inhibitor of caspase-1 and to a smaller extent caspase-4 and caspase-8, but not of the more distantly related caspase-3. PI9 is the first example of a human serpin analogue that inhibits members of this class of cysteine proteinases.
机译:尽管天冬氨酸残基参与严格调控的细胞过程,但对天冬氨酸残基后裂解其底物的半胱氨酸蛋白酶半胱氨酸蛋白酶的调控了解甚少。最近发现的丝氨酸蛋白酶抑制剂类似物蛋白酶抑制剂9(PI9)在人类丝氨酸蛋白酶抑制剂类似物中是独特的,因为它在反应位点环的推定特异性确定位置上具有酸性残基。我们测量了PI9抑制几种胱天蛋白酶的酰胺分解活性的能力。 PI9以时间依赖性方式抑制caspase-1(白介素-1β转换酶),caspase-4和caspase-8对肽底物的水解。 caspase-1与PI9的反应速率以及初始caspase-PI9复合物的底物水解速率显示出对PI9浓度的双曲线依赖性,这表明了抑制作用的两步动力学机制具有明显的抑制作用。二阶速率常数为7x10(2)M(-1).s(-1)。 caspase-3水解四肽底物不受PI9的抑制。可以免疫沉淀caspase-1和caspase-4与PI9的复合物,但无法检测到caspase-3的复合物。如果胱天蛋白酶的活性位点被共价抑制剂封闭,则复合物不能被免疫沉淀。这些结果表明PI9是caspase-1的抑制剂,并且在较小程度上是caspase-4和caspase-8的抑制剂,但不是更远相关的caspase-3的抑制剂。 PI9是抑制这种半胱氨酸蛋白酶成员的人丝氨酸蛋白酶抑制剂类似物的第一个例子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号